Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma

NCT03389230 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Malignant Glioma
Recurrent Glioma
Refractory Glioma
WHO Grade III Glioma

Interventions

BIOLOGICAL: HER2(EQ)BBζ/CD19t+ T cells
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Leukapheresis

Sponsor

City of Hope Medical Center

Collaborators

[object Object]